VALYSTR · Stock research
Listed on NasdaqGS. What the market is pricing into Myriad Genetics, Inc. (MYGN) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Diagnostics & Research · market value about $578M · revenue $807M (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows